News and Events Recent News Mar 17, 2020 Arrowhead Pharmaceuticals Announces Precautionary Measures to Mitigate Effects of Novel Coronavirus (COVID-19) Spread Mar 17, 2020 Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) Mar 3, 2020 Arrowhead Pharmaceuticals Initiates Phase 1/2 Study of ARO-HSD in Normal Healthy Volunteers and Patients with NASH or Suspected NASH View More » Recent Events Mar 18, 2020 Oppenheimer 30th Annual Healthcare Conference Mar 17, 2020 5th Annual Oligonucleotide & Precision Therapeutics Congress Mar 11, 2020 Barclays Global Healthcare Conference View More »
Mar 17, 2020 Arrowhead Pharmaceuticals Announces Precautionary Measures to Mitigate Effects of Novel Coronavirus (COVID-19) Spread
Mar 17, 2020 Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)
Mar 3, 2020 Arrowhead Pharmaceuticals Initiates Phase 1/2 Study of ARO-HSD in Normal Healthy Volunteers and Patients with NASH or Suspected NASH